Aspirin can reduce cancer risk: Study

A new research has revealed that an aspirin a day reduces cancer risk significantly


Researchers have found more medical uses for aspirin

An aspirin a day could dramatically cut people's chances of getting and dying from common cancers, according to recent research. A research team led by Professor Jack Cuzick, head of the center for cancer prevention at Queen Mary University of London, concluded that people between 50 and 65 years should consider taking 75mg low-dosage tablets of aspririn regularly.

Prof. Cuzick said that taking aspirin "looks to be the most important thing we can do to reduce cancer after stopping smoking and reducing obesity, and will probably be much easier to implement."

Aspirin was originally developed as a painkiller and a treatment for fever and inflammation, but more than a century after it was first synthesized from a Willow bark tree, researchers have found many medical uses for it.
It has demonstrated its effectiveness in reducing the risk of heart attacks and strokes as well as the chances of occurence of some cancers. But the big question has been whether the benefits outweigh the harm, because aspirin can cause stomach bleeds, which could be potentially fatal in some people.

The study published in the journal Annals of Oncology, revealed that by taking low-dose aspirin every day for ten years, bowel cancer cases were cut by about 35 percent and deaths by 40 percent. Aspirin could reduce rates of oesophageal and stomach cancers by 30 percent and death from them by 35 percent to 50 percent.

He said people considering embarking on a regime of daily aspirin should talk to their GP and get tested for potential risks first.


Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email